Select Medical Holdings (SEM) Liabilities and Shareholders Equity (2018 - 2026)

Select Medical Holdings has disclosed Liabilities and Shareholders Equity across 9 years of filings, most recently posting $6.0 billion for Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity rose 3298.74% year-over-year to $6.0 billion; the TTM figure through Mar 2026 stood at $23.3 billion (up 224.36% YoY), while the FY2025 annual figure was $5.9 billion, up 4.34% from the prior year.
• Liabilities and Shareholders Equity grew to $6.0 billion in Q1 2026, from $5.9 billion in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for SEM reached as high as $7.7 billion in Q2 2023 and fell as low as $162.9 million in Q3 2024.
• The 5-year median for Liabilities and Shareholders Equity is $5.7 billion (2025), against an average of $5.0 billion.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity plunged 97.88% — and 2025, when it jumped 3389.52%.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.2 billion in 2022, then jumped by 346.33% to $5.4 billion in 2023, then advanced by 4.64% to $5.6 billion in 2024, then gained by 4.34% to $5.9 billion in 2025, then advanced by 3.26% to $6.0 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $6.0 billion, $5.9 billion, and $5.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.